MEDP Valuation

Medpace Holdings Inc

Add to Watchlist

Advanced Chart

423.090

-4.11(-0.962%)1D

Overview
Forecast
Valuation
Earnings

MEDP Relative Valuation

MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MEDP is overvalued; if below, it's undervalued.

Historical Valuation

Medpace Holdings Inc (MEDP) is now in the Fair zone, suggesting that its current forward PE ratio of 28.85 is considered Fairly compared with the five-year average of 29.73. The fair price of Medpace Holdings Inc (MEDP) is between 374.92 to 503.66 according to relative valuation methord.

Relative Value

Fair Zone

374.92-503.66

Current Price：427.20

Fair

28.85

Trailing

Forward

22.82

EV/EBITDA

Medpace Holdings Inc. (MEDP) has a current EV/EBITDA of 22.82. The 5-year average EV/EBITDA is 21.99. The thresholds are as follows: Strongly Undervalued below 14.41, Undervalued between 14.41 and 18.20, Fairly Valued between 25.77 and 18.20, Overvalued between 25.77 and 29.56, and Strongly Overvalued above 29.56. The current Forward EV/EBITDA of 22.82 falls within the Historic Trend Line -Fairly Valued range.

24.04

EV/EBIT

Medpace Holdings Inc. (MEDP) has a current EV/EBIT of 24.04. The 5-year average EV/EBIT is 23.96. The thresholds are as follows: Strongly Undervalued below 15.42, Undervalued between 15.42 and 19.69, Fairly Valued between 28.23 and 19.69, Overvalued between 28.23 and 32.50, and Strongly Overvalued above 32.50. The current Forward EV/EBIT of 24.04 falls within the Historic Trend Line -Fairly Valued range.

4.69

Medpace Holdings Inc. (MEDP) has a current PS of 4.69. The 5-year average PS is 4.40. The thresholds are as follows: Strongly Undervalued below 2.83, Undervalued between 2.83 and 3.61, Fairly Valued between 5.19 and 3.61, Overvalued between 5.19 and 5.97, and Strongly Overvalued above 5.97. The current Forward PS of 4.69 falls within the Historic Trend Line -Fairly Valued range.

20.66

P/OCF

Medpace Holdings Inc. (MEDP) has a current P/OCF of 20.66. The 5-year average P/OCF is 21.57. The thresholds are as follows: Strongly Undervalued below 13.75, Undervalued between 13.75 and 17.66, Fairly Valued between 25.47 and 17.66, Overvalued between 25.47 and 29.38, and Strongly Overvalued above 29.38. The current Forward P/OCF of 20.66 falls within the Historic Trend Line -Fairly Valued range.

22.18

P/FCF

Medpace Holdings Inc. (MEDP) has a current P/FCF of 22.18. The 5-year average P/FCF is 24.67. The thresholds are as follows: Strongly Undervalued below 14.50, Undervalued between 14.50 and 19.58, Fairly Valued between 29.76 and 19.58, Overvalued between 29.76 and 34.84, and Strongly Overvalued above 34.84. The current Forward P/FCF of 22.18 falls within the Historic Trend Line -Fairly Valued range.

Medpace Holdings Inc (MEDP) has a current Price-to-Book (P/B) ratio of 69.72. Compared to its 3-year average P/B ratio of 17.50 , the current P/B ratio is approximately 298.37% higher. Relative to its 5-year average P/B ratio of 13.44, the current P/B ratio is about 418.61% higher. Medpace Holdings Inc (MEDP) has a Forward Free Cash Flow (FCF) yield of approximately 4.71%. Compared to its 3-year average FCF yield of 4.95%, the current FCF yield is approximately -4.74% lower. Relative to its 5-year average FCF yield of 4.62% , the current FCF yield is about 2.10% lower.

69.72

P/B

Median3y

17.50

Median5y

13.44

4.71

FCF Yield

Median3y

4.95

Median5y

4.62

Competitors Valuation Multiple

The average P/S ratio for MEDP's competitors is 2.96, providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP) exhibits a P/S ratio of 4.69, which is 58.60% above the industry average. Given its robust revenue growth of 14.24%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Booz Allen Hamilton Holding Corp

Performance Decomposition

Market capitalization of MEDP increased by 20.25% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 27.34 to 31.87.

The secondary factor is the Revenue Growth, contributed 14.24%to the performance.

Overall, the performance of MEDP in the past 1 year is driven by P/E Change. Which is more unsustainable.

14.24%

528.10M → 603.31M

Revenue Growth

-10.58%

16.73 → 14.96

Margin Expansion

16.59%

27.34 → 31.87

P/E Change

20.25%